3174 Tumor suppressors p53 and ARF control oncogenic potential of triple-negative breast cancer cells by regulating RNA editing enzyme ADAR1
OBJECTIVES/SPECIFIC AIMS: Triple-negative breast cancer (TNBC) accounts for one-fifth of the breast cancer patient population. The heterogeneous nature of TNBC and lack of options for targeted therapy make its treatment a constant challenge. The co-deficiency of tumor suppressors p53 and ARF is a si...
Збережено в:
| Автори: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Cambridge University Press
2019-03-01
|
| Серія: | Journal of Clinical and Translational Science |
| Онлайн доступ: | https://www.cambridge.org/core/product/identifier/S205986611900061X/type/journal_article |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|